SCHEMBL19843547

SCHEMBL19843547

Cc1nc(C)nc(-c2ccc3c4ccccc4n(-c4cccc5c4C(=O)N(c4cccc(-c6ccccc6)c4)C5=O)c3c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYMS P04818 2/20 0.40
▸ HPSE Q9Y251 3/20 0.36
▸ PDE6D O43924 1/20 0.36
▸ MEN1 O00255 3/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ HTT P42858 2/20 0.35
▸ USP2 O75604 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TNNI3 P19429 1/20 0.35
▸ TNNT2 P45379 1/20 0.35
▸ TNNC1 P63316 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PDE10A Q9Y233 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ HSPA1A P0DMV8 1/20 0.34
▸ PABPC1 P11940 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ FAAH O00519 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19842696 0.97 TYMS (0.42) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL19842702 0.94 TYMS (0.40) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL19843468 0.94 TYMS (0.38) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL19843414 0.94 PDE6D (0.42) TYMSPDE6DMEN1KMT2AHTT
SCHEMBL19843335 0.93 TYMS (0.39) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL23476522 0.92 TYMS (0.40) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL23476541 0.92 TYMS (0.42) TYMSHPSEPDE6DMEN1KMT2A
SCHEMBL19843554 0.92 PDE6D (0.44) TYMSPDE6DMEN1KMT2AHTT
SCHEMBL19843475 0.91 TYMS (0.45) TYMSHPSEPDE6DHTTLMNA
SCHEMBL19843330 0.90 TYMS (0.42) TYMSPDE6DMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3494112-B1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2022-04-20 — — EP disclosed
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 — — US disclosed
WO-2018024725-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-08 — — WO disclosed
EP-3279194-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171501-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES L1CAM, OR10J3, AOX1 TYMS 2154/4885HPSE 3648/4885PDE6D 923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback